Additionally, immunostaining assays demonstrated extensive expression of CD133 in the tumor sphere samples (Fig. 1C), while lower levels of CD133 expression were detected in the primary lung cancer cells (Fig. 1D). This evidence concerns the gene PROM1 and lung cancer.